share_log

HC Wainwright & Co. Reiterates Buy on Reneo Pharmaceuticals, Maintains $30 Price Target

HC Wainwright & Co. Reiterates Buy on Reneo Pharmaceuticals, Maintains $30 Price Target

HC Wainwright & Co.重申买入瑞诺制药,维持30美元的目标股价
Benzinga ·  2023/10/12 06:26

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Reneo Pharmaceuticals (NASDAQ:RPHM) with a Buy and maintains $30 price target.

HC Wainwright&Co.分析师米切尔·卡普尔重申雷诺制药(纳斯达克:RPHM)买入,并维持30美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发